Skip to main content
Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.090
-0.010 (-0.91%)
At close: Dec 5, 2025, 4:00 PM EST
1.080
-0.010 (-0.92%)
After-hours: Dec 5, 2025, 7:59 PM EST

Gelteq Revenue

In the fiscal year ending June 30, 2025, Gelteq had annual revenue of 413.13K AUD with 188.27% growth. Gelteq had revenue of 101.72K in the half year ending June 30, 2025.

Revenue (ttm)
413.13K AUD
Revenue Growth
+188.27%
P/S Ratio
37.32
Revenue / Employee
51,642 AUD
Employees
8
Market Cap
11.68M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 2025413.13K269.82K188.27%
Jun 30, 2024143.31K-199.59K-58.21%
Jun 30, 2023342.90K-29.17K-7.84%
Jun 30, 2022372.07K212.20K132.73%
Jun 30, 2021159.87K--
Jun 30, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

GELS News

More News